Wakefulness-Promoting Agents

Name
Wakefulness-Promoting Agents
Accession Number
DBCAT001105
Description

A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat DISORDERS OF EXCESSIVE SOMNOLENCE such as NARCOLEPSY. Note that this drug category does not include broadly-acting central nervous system stimulants such as AMPHETAMINES.

Drugs
DrugDrug Description
ModafinilA stimulant used to improve wakefulness in patients with sleep apnea, narcolepsy, or shift work disorder.
ArmodafinilA stimulant used to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea, narcolepsy, or shift work disorder.
Drugs & Drug Targets
DrugTargetType
ModafinilSodium-dependent dopamine transportertarget
ModafinilAlpha-1B adrenergic receptortarget
ModafinilCytochrome P450 3A4enzyme
ModafinilCytochrome P450 2C19enzyme
ModafinilCytochrome P450 1A2enzyme
ModafinilCytochrome P450 2B6enzyme
ModafinilCytochrome P450 2C9enzyme
ModafinilCytochrome P450 3A5enzyme
ArmodafinilCytochrome P450 2C19enzyme
ArmodafinilCytochrome P450 3A4enzyme
ArmodafinilCytochrome P450 1A2enzyme
ArmodafinilCytochrome P450 2B6enzyme
ArmodafinilCytochrome P450 3A5enzyme
ArmodafinilCytochrome P450 2C9enzyme
ArmodafinilSodium-dependent dopamine transportertarget